- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02287948
Wii FIT Balance Board to Recording Balance Parameters in Multiple Sclerosis Subjects
Validation Study for Using Wii FIT Balance Board to Recording Balance Parameters in Healthy Subjects and Multiple Sclerosis Subjects
Balance disorders are frequently observed in patients with Multiple Sclerosis (MS) and the deterioration of the static and dynamic control of balance is an important and basic symptom of disease progression.
Measure balance disorders with force platforme requires personnel and represent a significant cost.
The platform Nintendo Wii Fit represents a valid economic alternative
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Balance disorders are frequently observed in patients with MS and are the most disabling symptoms; in subjects with moderate disabilities for balance, the deterioration of the static and dynamic control of balance is an important and basic symptom of disease progression.
From a clinical point of view, the reliability of being able to discriminate patients who have the highest probability of falling than those with lower probability is crucial to develop a program aimed at the prevention of falls.
Potentially the parameters measured wiht torque platform can be an objective, reliable and accurate for discriminating patients with the highest probability of falling than those with low probability, and may be useful to highlight the deficits and improvements in the ability to maintain balance after specific rehabilitation. However posturographic systems represent a significant cost, require a dedicated and qualified personnel to use. A possible solution to not use force platforms could be the implementation of software to interface with the Nintendo Wii Fit Balance Board (WBB) with a personal computer.
The platform Nintendo Wii Fit presents a set of sensors lower compared to a traditional force platform, but can represent a valid economic alternative to more complex systems, in addition to being already used as a rehabilitation tool in the literature in more than one study. Studies in healthy subjects have valid information on the study of the center of pressure (COP) obtained from WBB showing that the path lengths of the COP obtained from the WBB were valid and well correlated with those recorded by a dynamometric platform.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Ferrara, Italy, 44124
- Ferrara University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria (Healthy subjects):
- Male and female, aged > 18, < 80 years;
- healthy.
Exclusion Criteria (Healthy subjects):
- pregnancy;
- previous diagnosis of debilitating diseases;
- previous diagnosis of orthopedic, neurological, vestibular or that may affect the balance.
Inclusion Criteria (Multiple Sclerosis subjects):
- Male and female, aged > 18, < 80 years;
- subjects with a diagnosis of MS according to the McDonald criteria in course with relapse and remission, progressive, primary or secondary are included in the study;
- absence of disease exacerbations in the 3 months prior to enrollment;
- mild or moderate gait disability identified with the Expanded Disability Status Scale (EDSS) score not higher than 5.5. This degree of severity refers to a subject with restriction ambulatory activity but which does not require constantly an unilateral support (stick, crutch, other) for walking.
Exclusion Criteria (Multiple Sclerosis subjects):
- cognitive impairment assessed with Mini Mental Status Examination (MMSE) <24;
- neurological diseases associated with MS with possible involvement of motor functions;
- of internal conditions that might interfere with the ability to complete the study protocol in a secure manner;
- severe cognitive-behavioral (score less than 24 on the Mini Mental Status Examination);
- pregnancy;
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
MS subjects group
Multiple sclerosis subjects wiht mild-moderate gait disability with EDSS score not higher than 5.5
|
Clinical and instrumental evaluations carry out on the same day. 1) Instrumental evaluations All subjects (healthy + MS) will ask to perform the following tasks both on force platform and Wii Fit Balance Board:
During trials subjects can leave arms in the most comfortable position they prefere Subjects will perform every task for 5 times; they can rest for 30 seconds between every trials. |
|
Healthy subjects group
Healthy subjects age-matched with multiple sclerosis subjects.
|
Clinical and instrumental evaluations carry out on the same day. 1) Instrumental evaluations All subjects (healthy + MS) will ask to perform the following tasks both on force platform and Wii Fit Balance Board:
During trials subjects can leave arms in the most comfortable position they prefere Subjects will perform every task for 5 times; they can rest for 30 seconds between every trials. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parameters related with postural balance and the chance to fall
Time Frame: one evaluation in one day
|
Instrumental evaluations carry out on the same day. All subjects will perform the following tasks both on force platform and Wii Fit Balance Board:
During trials subjects can leave arms in the most comfortable position they prefere Subjects will perform every task for 5 times; they can rest for 30 seconds between every trials. |
one evaluation in one day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Timed "up and go" test (TUG)
Time Frame: one evaluation in one day
|
Timed "up and go" test validity has been demonstrated with Berg Balance test correlation, gait speed and ability to step on the stairs; this test has been recently validated for multiple sclerosis subjects evaluation.
|
one evaluation in one day
|
|
Dynamic Gait Index (DGI)
Time Frame: one evaluation in one day
|
DGI indicates the subject's ability to adapt walking patterns according to environmental changes (ie changes in the speed, turn the head, climb over or around obstacles or stairs).
The DGI was created to assess the balance dysfunction in individuals with alterations in the way of vestibular apparatus, but it represents a reliable assessment scale for subjects with multiple sclerosis (McConvey 2005).
|
one evaluation in one day
|
|
Berg Balance Scale
Time Frame: one evaluation in one day
|
This scale tests static and dynamic activities.
The level of each item has a score range 0-4 determined the ability of the patient to the ability to perform the task tested.
The results of each item are added together, the total score is 56.
|
one evaluation in one day
|
|
Unified Balance Scale - Unified Balance Scale (UBS)
Time Frame: one evaluation in one day
|
The 27 items that make up the UBS are part of the existing three scales: Berg Balance Sclale (BBS), Performance Oriented Mobility Scale (Scale and Tinetti POMA) and Fullerton Advanced Balance Scale (FABS).
|
one evaluation in one day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sofia Straudi, Ospedale San Giorgio
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- WII Balance Board_MS
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Nintendo Wii Fit Balance Board
-
University Health Network, TorontoTerminatedVestibular Diseases | Disturbance; Balance, LabyrinthCanada
-
University of British ColumbiaCompletedBelow Knee AmputationCanada
-
Hitit UniversityCompletedMotor Learning | Virtual Reality Based Therapy | Agility | Ankle DorsiflexionTurkey (Türkiye)
-
Riphah International UniversityCompletedCerebral Palsy | Balance ProblemPakistan
-
University of Missouri-ColumbiaWithdrawnDistorted; BalanceUnited States
-
Biruni UniversityIstanbul UniversityCompleted
-
Sao Camilo University CenterCompleted
-
Cairo UniversityCompletedOsteoporosis | MastectomyEgypt
-
Manuel Gomez, MD, MSc.CompletedArthropathy of Knee JointCanada
-
Queen's UniversityWalmartCompletedChronic SchizophreniaCanada